Clinical Trial Update: Adjuvant Cytokine Therapy to Treat Pulmonary Mycobacterium Avium Complex Infection [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating adjuvant cytokine therapy for pulmonary Mycobacterium avium complex infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycobacterium Avium Complex Infection

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Mycobacterium Avium-Intracellulare Infection | Phase 1 | Status: COMPLETED